Evidence map›Paper›PMID 41826799›Full record

ArticleBioinformatics (Oxford, England)2026

Competing subclones and fitness diversity shape tumor evolution across cancer types.

Hai Chen, Jingmin Shu, Rekha Mudappathi, Elaine Li, Panwen Wang, Leif Bergsagel, Ping Yang, Zhifu Sun, Logan Zhao, Changxin Shi and 3 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Hai ChenCollege of Health Solutions, Arizona State University, Phoenix, AZ 85004, United States.
Jingmin ShuCollege of Health Solutions, Arizona State University, Phoenix, AZ 85004, United States.
Rekha MudappathiCollege of Health Solutions, Arizona State University, Phoenix, AZ 85004, United States.
Elaine LiEmory University, Atlanta, GA 30322, United States.
Panwen WangDepartment of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, United States.
Leif BergsagelComprehensive Cancer Center, Mayo Clinic, Scottsdale, AZ 85054, United States.
Ping YangDivision of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, United States.ORCID 0000-0002-8588-847X
Zhifu SunDivision of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, United States.
Logan ZhaoDivision of Hematology/Oncology, Department of Medicine, Mayo Clinic, Scottsdale, AZ 85259, United States.
Changxin ShiDivision of Hematology/Oncology, Department of Medicine, Mayo Clinic, Scottsdale, AZ 85259, United States.
Jeffrey P TownsendDepartment of Biostatistics, Yale School of Public Health, New Haven, CT 06520, United States.ORCID 0000-0002-9890-3907
Carlo MaleyBiodesign Institute, Arizona State University, Tempe, AZ 85281, United States.ORCID 0000-0002-0745-7076
Li LiuCollege of Health Solutions, Arizona State University, Phoenix, AZ 85004, United States.ORCID 0000-0003-4002-7497

Funding

Interdisciplinary Systems-based Training for Precision NutritionT32DK137525 · NIDDK · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Li Liu, Corrie Marie Whisner · 2023 to 2026
$1.4M
National Institutes of Health of the United States R01LM013438NIDDK NIH HHS T32 DK137525
6 · The paper itself

Abstract

motivationIntratumor heterogeneity arises from ongoing somatic evolution and complicates cancer diagnosis, prognosis, and treatment. Reconstructing evolutionary dynamics typically requires spatiotemporal samples, which are often unavailable in clinical settings. Computational approaches that can infer tumor evolutionary history from single-timepoint bulk sequencing data remain limited.

resultsWe present estimating evolutionary events through single-timepoint sequencing (TEATIME), a novel computational framework that models tumors as mixtures of two competing cell populations: an ancestral clone with baseline fitness and a derived subclone with elevated fitness. Using cross-sectional bulk sequencing data, TEATIME estimates mutation rates, timing of subclone emergence, relative fitness, and number of generations of growth. To quantify intratumor fitness asymmetries, we introduce a novel metric-fitness diversity-which captures the imbalance between competing cell populations and serves as a measure of functional intratumor heterogeneity. Applying TEATIME to 33 tumor types from The Cancer Genome Atlas, we revealed divergent as well as convergent evolutionary patterns. Notably, we found that immune-hot microenvironments constraint subclonal expansion and limit fitness diversity. Moreover, we detected temporal dependencies in mutation acquisition, where early driver mutations in ancestral clones epistatically shape the fitness landscape, predisposing specific subclones to selective advantages. These findings underscore the importance of intratumor competition and tumor-microenvironment interactions in shaping evolutionary trajectories, driving intratumor heterogeneity. Lastly, we demonstrate that TEATIME-derived evolutionary parameters and fitness diversity offer novel prognostic insights across multiple cancer types. AVAILABILITY AND IMPLEMENTATION: R implementation of TEATIME is available on GitHub (https://github.com/liliulab/TEATIME) and Zenodo (https://zenodo.org/records/17422174).

Indexed as

Computational BiologyEvolution, MolecularGenetic FitnessNeoplasmsHumansMutation

Identifiers

PMID41826799
PMCPMC13025073

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.